Data I/O Reports Fourth Quarter 2021 Results
Data I/O Corporation (NASDAQ: DAIO) reported a strong financial performance for the fourth quarter and full year 2021. Net sales increased by 29% to $6.4 million in Q4, with a full year revenue growth of 27% to $25.8 million. The company achieved a gross margin of 54.4% in Q4 and 57.0% for the year. Despite a net loss of ($205,000) in Q4 and ($555,000) for the year, adjusted EBITDA improved to $117,000 in Q4 and $1.5 million for 2021. The solid demand in automotive electronics and a growing installed base of PSV systems were key drivers of growth.
- 27% year-over-year revenue growth in 2021, reaching $25.8 million.
- Fourth-quarter net sales increased by 29% compared to Q4 2020.
- Achieved adjusted EBITDA of $1.5 million for the full year 2021.
- Gross margin improved to 57.0% for the full year.
- Strong cash position with $14.2 million and no debt.
- Net loss of ($205,000) in Q4 2021, despite revenue growth.
- Backlog decreased to $2.9 million at year-end from $3.3 million in Q3 2021.
Fourth Quarter 2021 Highlights
-
Net sales of
, up$6.4 million 29% from the prior year; bookings of$6.2 million -
Quarter-end backlog of
$2.9 million -
Gross margin as a percentage of sales of
54.4% -
Net loss of (
) or ($205,000 ) per share$0.02 -
Adjusted EBITDA* of
$117,000 -
Cash & Equivalents of
; no debt$14.2 million - Received 2021 GLOBAL Technology Award for SentriX Product Creator™ tool suite
Full Year 2021 Highlights
-
Net sales of
, up$25.8 million 27% from the prior year; bookings of$25.5 million -
Gross margin as a percentage of sales of
57.0% -
Net loss of (
) or ($555,000 ) per share$0.06 -
Adjusted EBITDA of
$1.5 million -
Automotive Electronics represented58% of bookings for 2021 -
Increased SentriX® bookings and revenue over
100% - Deployment of over 390 PSV systems worldwide
*Adjusted EBITDA is a non-GAAP financial measure. A reconciliation is provided in the tables of this press release.
Management Comments
Commenting on the fiscal year ended
“A critical component of our plan are increases in recurring revenues associated with sales of consumable adapters, software and services. Our increasing installed base of PSV machines provides recurring and consumable revenues which supplement our capital equipment sales. At the end of 2021, our PSV installed base increased to over 390 systems, up from approximately 330 at the end of the prior year. For the first time, we sold a SentriX system to an OEM. This sale included a recurring software license. We also announced the first upgrade of an installed PSV machine to add secure provisioning. We have proven in 2021 that we can monetize our software and equipment to serve the needs of our clients while bolstering our financial position. Total consumable revenue grew for the fourth consecutive year on the strength of adapter sales.
“The resiliency of our supply chain has been a strong mitigating factor that led to our improved performance, which included gross margins increasing to
“Bookings of
“As we look forward to 2022, celebrating our 50th year in business, we are confident that our industry leading secure programming technology platform, automotive momentum, resilient supply chain and strong balance sheet position us to capitalize on demand supported by exciting high growth secular trends. We are planning for double-digit bookings growth, consistent with the long-term double-digit semiconductor growth rate in the automotive electronics industry. We are planning for significantly higher SentriX growth rates building off of our record 2021.”
Fourth Quarter and Full Year 2021 Financial Results
Net sales in the fourth quarter of 2021 were
Fourth quarter 2021 bookings were
Gross margin as a percentage of sales was
Net loss in the fourth quarter of 2021 was (
Adjusted earnings before interest, taxes, depreciation and amortization, which excludes equity compensation, impairment and related non-cash, one-time items, (“Adjusted EBITDA”) was
Data I/O’s financial condition remained strong with cash of
Conference Call Information
A conference call discussing financial results for the fourth quarter ended
About
Since 1972
Learn more at dataio.com
Forward Looking Statement and Non-GAAP financial measures
Statements in this news release concerning economic outlook, expected revenue, expected margins, expected savings, expected results, orders, deliveries, backlog and financial positions, silicon chip shortages, supply chain expectations, as well as any other statement that may be construed as a prediction of future performance or events are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statement disclaimers also apply to the global COVID-19 pandemic, including the expected effects on the Company’s business from COVID-19, the duration and scope, impact on the demand for the Company’s products, and the pace of recovery for the COVID-19 pandemic to subside. These factors include uncertainties as to the ability to record revenues based upon the timing of product deliveries, installations and acceptance, accrual of expenses, coronavirus related business interruptions, changes in economic conditions, part shortages and other risks including those described in the Company's filings on Forms 10-K and 10-Q with the
Non-GAAP financial measures, such as EBITDA, Adjusted EBITDA excluding equity compensation and impairment & related charges, and Adjusted gross margin should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding the Company’s results and facilitate the comparison of results.
- tables follow -
CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) (UNAUDITED) |
||||||||
Three Months Ended
|
|
Twelve Months Ended
|
||||||
2021 |
|
2020 |
|
2021 |
|
2020 |
||
|
|
|
|
|
||||
Cost of goods sold |
2,900 |
2,619 |
11,115 |
9,506 |
||||
Gross margin |
3,457 |
2,322 |
14,720 |
10,822 |
||||
Operating expenses: |
||||||||
Research and development |
1,626 |
1,594 |
6,635 |
6,357 |
||||
Selling, general and administrative |
2,026 |
1,567 |
8,358 |
6,891 |
||||
Impairment |
- |
652 |
- |
652 |
||||
Total operating expenses |
3,652 |
3,813 |
14,993 |
13,900 |
||||
Operating income (loss) |
(195) |
(1,491) |
(273) |
(3,078) |
||||
Non-operating income (loss): |
||||||||
Interest income |
- |
1 |
11 |
14 |
||||
Gain on sale of assets |
21 |
- |
21 |
- |
||||
Foreign currency transaction gain (loss) |
(138) |
(211) |
(202) |
(513) |
||||
Total non-operating income (loss) |
(117) |
(210) |
(170) |
(499) |
||||
Income (loss) before income taxes |
(312) |
(1,701) |
(443) |
(3,577) |
||||
Income tax (expense) benefit |
107 |
55 |
(112) |
(387) |
||||
Net income (loss) |
( |
( |
( |
( |
||||
Basic earnings (loss) per share |
( |
( |
( |
( |
||||
Diluted earnings (loss) per share |
( |
( |
( |
( |
||||
Weighted-average basic shares |
8,621 |
8,416 |
8,545 |
8,333 |
||||
Weighted-average diluted shares |
8,621 |
8,416 |
8,545 |
8,333 |
CONSOLIDATED BALANCE SHEETS (in thousands, except share data) (UNAUDITED) |
|||
|
|
||
ASSETS |
|||
CURRENT ASSETS: |
|||
Cash and cash equivalents |
|
|
|
Trade accounts receivable, net of allowance for |
|||
doubtful accounts of |
3,995 |
2,494 |
|
Inventories |
6,351 |
5,270 |
|
Other current assets |
737 |
1,319 |
|
TOTAL CURRENT ASSETS |
25,273 |
23,250 |
|
Property, plant and equipment – net |
946 |
1,216 |
|
Other assets |
2,838 |
1,126 |
|
TOTAL ASSETS |
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|||
CURRENT LIABILITIES: |
|||
Accounts payable |
|
|
|
Accrued compensation |
2,496 |
1,509 |
|
Deferred revenue |
1,507 |
1,068 |
|
Other accrued liabilities |
1,413 |
1,307 |
|
Income taxes payable |
- |
62 |
|
TOTAL CURRENT LIABILITIES |
6,789 |
5,191 |
|
Operating lease liabilities |
2,277 |
588 |
|
Long-term other payables |
138 |
174 |
|
COMMITMENTS |
- |
- |
|
STOCKHOLDERS’ EQUITY |
|||
Preferred stock - |
|||
Authorized, 5,000,000 shares, including |
|||
200,000 shares of Series A Junior Participating |
|||
Issued and outstanding, none |
- |
- |
|
Common stock, at stated value - |
|||
Authorized, 30,000,000 shares |
|||
Issued and outstanding, 8,621,007 shares as of |
|||
2021 and 8,416,335 shares as of |
20,886 |
20,071 |
|
Accumulated earnings (deficit) |
(2,011) |
(1,456) |
|
Accumulated other comprehensive income |
978 |
1,024 |
|
TOTAL STOCKHOLDERS’ EQUITY |
19,853 |
19,639 |
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
NON-GAAP FINANCIAL MEASURE RECONCILIATION |
||||||||
Three Months Ended
|
|
Twelve Months Ended
|
||||||
2021 |
|
2020 |
|
2021 |
|
2020 |
||
(in thousands) |
||||||||
Net Income (loss) |
( |
( |
( |
( |
||||
Interest (income) |
- |
(1) |
(11) |
(14) |
||||
Taxes |
(107) |
(55) |
112 |
387 |
||||
Depreciation and amortization |
150 |
194 |
667 |
815 |
||||
EBITDA earnings (loss) |
( |
( |
|
( |
||||
Equity compensation |
279 |
371 |
1,238 |
1,467 |
||||
Impairment & related |
- |
943 |
- |
943 |
||||
Adjusted EBITDA, excluding equity compensation |
|
|||||||
and impairment & related charges |
|
( |
|
( |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220224005922/en/
Chief Operating and Financial Officer
(512) 551-9296
jdarrow@darrowir.com
Source:
FAQ
What were Data I/O's Q4 2021 financial results?
How did Data I/O perform in 2021?
What contributed to Data I/O's revenue growth in 2021?
What is Data I/O's current cash position?